Success Metrics

Active Trials
2(100%)

Phase Distribution

Ph phase_4
1
50%
Ph phase_1
1
50%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

2

all time

Status Distribution
Active(2)

Detailed Status

Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
2
Active
2
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 11 (50.0%)
Phase 41 (50.0%)

Trials by Status

recruiting2100%

Recent Activity

2 active trials
Showing 2 of 2
recruitingphase_4

Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease

NCT07077486
recruitingphase_1

A Single Dose Study to Investigate the Pharmacokinetics (PK) of Telitacicept Pre-filled Injection and Freeze-dried Powder Injection in Chinese Healthy Subjects

NCT06549959

Clinical Trials (2)

Showing 2 of 2 trials
NCT07077486Phase 4

Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease

Recruiting
NCT06549959Phase 1

A Single Dose Study to Investigate the Pharmacokinetics (PK) of Telitacicept Pre-filled Injection and Freeze-dried Powder Injection in Chinese Healthy Subjects

Recruiting

All 2 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
2